Late last week, reports emerged that the National Institutes of Health (NIH), a major U.S. government agency responsible for biomedical research, had struck a deal with the Department of Defense (DOD) to redirect part of its budget toward DOD projects. This agreement was confirmed by the DOD on a Friday before a major U.S. holiday, with the department releasing a copy of the signed agreement, which it said had been finalized about a month earlier. The deal has raised questions, especially since it involves shifting funds from the NIH—typically focused on health research—to the DOD, which is primarily responsible for national defense and military operations. The agreement outlines a system where the NIH would transfer funds to the DOD to support research on medical countermeasures against threats such as pandemic influenza, chemical and biological agents, and emerging infectious diseases. These funds would come from the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), which has been allocated $6.6 billion for 2026 by Congress. The agreement is set to last for 10 years, though the exact amount of the NIAID budget that will be redirected to the DOD remains unclear. According to reports from the journal Nature, the DOD had initially sought up to a third of its total budget from the NIH but was eventually offered around 10 percent. This discrepancy highlights the massive difference in size between the two agencies. The DOD’s 2026 budget is estimated at around $1 trillion, though it is under pressure due to ongoing, unpredictable conflicts, such as the situation with Iran. Meanwhile, the NIH has faced its own challenges, including difficulties in distributing the funds it receives from Congress. The timing of the agreement has also drawn attention, as the NIH has struggled to issue grants and allocate its resources effectively. Critics argue that redirecting funds to the DOD could further strain the NIH’s ability to support critical health research. However, supporters of the deal suggest it could help bridge gaps in preparedness for biological and other threats, aligning health and defense priorities in a time of global uncertainty.